Adverse outcomes of anticoagulant use among hospitalized patients with chronic kidney disease: a comparison of the rates of major bleeding events between unfractionated heparin and enoxaparin.
BACKGROUND: Anticoagulation therapy is usually required in patients with chronic kidney disease (CKD) for treatment or prevention of thromboembolic diseases. However, this benefit could easily be offset by the risk of bleeding. OBJECTIVES: To determine the incidence of adverse outcomes of anticoagul...
Main Authors: | Fatemeh Saheb Sharif-Askari, Syed Azhar Syed Sulaiman, Narjes Saheb Sharif-Askari, Ali Al Sayed Hussain, Mohammad Jaffar Railey |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4152258?pdf=render |
Similar Items
-
Development of an adverse drug reaction risk assessment score among hospitalized patients with chronic kidney disease.
by: Fatemeh Saheb Sharif-Askari, et al.
Published: (2014-01-01) -
Adverse drug reactions reported to the drug and poison information center of Tehran, Iran.
by: Fatemeh Saheb Sharif-Askari, et al.
Published: (2017-01-01) -
Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients
by: Thompson David, et al.
Published: (2006-09-01) -
The anticoagulant properties of unfractionated and fractionated heparins
by: MacGregor, I. R.
Published: (1980) -
The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false‐positive results?
by: Pieter M.M. De Kesel, et al.
Published: (2020-01-01)